Anzahl der Publikationen: 8
Zeitschriftenartikel
Lu, Yen-Shen; Im, Seock-Ah; Colleoni, Marco; Franke, Fabio; Bardia, Aditya; Cardoso, Fatima; Harbeck, Nadia; Hurvitz, Sara; Chow, Louis; Sohn, Joohyuk; Lee, Keun Seok; Campos-Gomez, Saul; Vazquez, Rafael Villanueva; Jung, Kyung Hae; Babu, K. Govind; Wheatley-Price, Paul; De Laurentiis, Michelino; Im, Young-Hyuck; Kuemmel, Sherko; El-Saghir, Nagi; O'Regan, Ruth; Gasch, Claudia; Solovieff, Nadia; Wang, Craig; Wang, Yongyu; Chakravartty, Arunava; Ji, Yan und Tripathy, Debu
(2022):
Updated Overall Survival of Ribociclib plus Endocrine Therapy versus Endocrine Therapy Alone in Pre- and Perimenopausal Patients with HR+/HER2(-) Advanced Breast Cancer in MONALEESA-7: A Phase III Randomized Clinical Trial.
In: Clinical Cancer Research, Bd. 28, Nr. 5: S. 851-859
Cristofanilli, Massimo; Rugo, Hope S.; Im, Seock-Ah; Slamon, Dennis J.; Harbeck, Nadia; Bondarenko, Igor; Masuda, Norikazu; Colleoni, Marco; DeMichele, Angela; Loi, Sherene; Iwata, Hiroji; O'Leary, Ben; Andre, Fabrice; Loibl, Sibylle; Bananis, Eustratios; Liu, Yuan; Huang, Xin; Kim, Sindy; Frean, Maria Jose Lechuga und Turner, Nicholas C.
(2022):
Overall Survival with Palbociclib and Fulvestrant in Women with HR+/HER2(- )ABC: Updated Exploratory Analyses of PALOMA-3, a Double-blind, Phase III Randomized Study.
In: Clinical Cancer Research, Bd. 28, Nr. 16: S. 3433-3442
Aftimos, Philippe; Oliveira, Mafalda; Irrthum, Alexandre; Fumagalli, Debora; Sotiriou, Christos; Gal-Yam, Einav Nili; Robson, Mark E.; Ndozeng, Justin; Di Leo, Angelo; Ciruelos, Eva M.; de Azambuja, Evandro; Viale, Giuseppe; Scheepers, Elsemieke D.; Curigliano, Giuseppe; Bliss, Judith M.; Reis-Filho, Jorge S.; Colleoni, Marco; Balic, Marija; Cardoso, Fatima; Albanell, Joan; Duhem, Caroline; Marreaud, Sandrine; Romagnoli, Dario; Rojas, Beatriz; Gombos, Andrea; Wildiers, Hans; Guerrero-Zotano, Angel; Hall, Peter; Bonetti, Andrea; Larsson, Karolina Fs; Degiorgis, Martina; Khodaverdi, Silvia; Greil, Richard; Sverrisdottir, Asgerdur; Paoli, Marta; Seyll, Ethel; Loibl, Sibylle; Linderholm, Barbro; Zoppoli, Gabriele; Davidson, Nancy E.; Johannsson, Oskar Th; Bedard, Philippe L.; Loi, Sherene; Knox, Susan; Cameron, David A.; Harbeck, Nadia; Montoya, Maite Lasa; Brandao, Mariana; Vingiani, Andrea; Caballero, Carmela; Hilbers, Florentine S.; Yates, Lucy R.; Benelli, Matteo; Venet, David und Piccart, Martine J.
(2021):
Genomic and Transcriptomic Analyses of Breast Cancer Primaries and Matched Metastases in AURORA, the Breast International Group (BIG) Molecular Screening Initiative.
In: Cancer Discovery, Bd. 11, Nr. 11: S. 2796-2811
Bardia, Aditya; Su, Fei; Solovieff, Nadia; Im, Seock-Ah; Sohn, Joohyuk; Lee, Keun Seok; Campos-Gomez, Saul; Jung, Kyung Hae; Colleoni, Marco; Villanueva Vazquez, Rafael; Franke, Fabio; Hurvitz, Sara; Harbeck, Nadia; Chow, Louis; Taran, Tetiana; Lorenc, Karen Rodriguez; Babbar, Naveen; Tripathy, Debu und Lu, Yen-Shen
(2021):
Genomic Profiling of Premenopausal HR+ and HER2-Metastatic Breast Cancer by Circulating Tumor DNA and Association of Genetic Alterations With Therapeutic Response to Endocrine Therapy and Ribociclib.
In: Jco Precision Oncology, Bd. 5: S. 1408-1420
Turner, Nicholas C.; Liu, Yuan; Zhu, Zhou; Loi, Sherene; Colleoni, Marco; Loibl, Sibylle; DeMichele, Angela; Harbeck, Nadia; Andre, Fabrice; Bayar, Mohamed Amine; Michiels, Stefan; Zhang, Zhe; Giorgetti, Carla; Arnedos, Monica; Bartlett, Cynthia Huang und Cristofanilli, Massimo
(2019):
Cyclin E1 Expression and Palbociclib Efficacy in Previously Treated Hormone Receptor-Positive Metastatic Breast Cancer.
In: Journal of Clinical Oncology, Bd. 37, Nr. 14
Denkert, Carsten; Budczies, Jan; Regan, Meredith M.; Loibl, Sibylle; Dell'Orto, Patrizia; Minckwitz, Gunter von; Mastropasqua, Mauro G.; Solbach, Christine; Thurlimann, Beat; Mehta, Keyur; Blohmer, Jens-Uwe; Colleoni, Marco; Müller, Volkmar; Klauschen, Frederick; Ataseven, Beyhan; Engels, Knut; Kammler, Roswitha; Pfitzner, Berit M.; Dietel, Manfred; Fasching, Peter A. und Viale, Giuseppe
(2019):
Clinical and analytical validation of Ki-67 in 9069 patients from IBCSG VIII+IX, BIG1-98 and GeparTrio trial: systematic modulation of interobserver variance in a comprehensive in silico ring trial.
In: Breast Cancer Research and Treatment, Bd. 176, Nr. 3: S. 557-568
Tripathy, Debu; Im, Seock-Ah; Colleoni, Marco; Franke, Fabio; Bardia, Aditya; Harbeck, Nadia; Hurvitz, Sara A.; Chow, Louis; Sohn, Joohyuk; Lee, Keun Seok; Campos-Gomez, Saul; Vazquez, Rafael Villanueva; Jung, Kyung Hae; Babu, K. Govind; Wheatley-Price, Paul; Laurentiis, Michelino de; Im, Young-Hyuck; Kümmel, Sherko; El-Saghir, Nagi; Liu, Mei-Ching; Carlson, Gary; Hughes, Gareth; Diaz-Padilla, Ivan; Germa, Caroline; Hirawat, Samit und Lu, Yen-Shen
(2018):
Ribociclib plus endocrine therapy for premenopausal women with hormone-receptor-positive, advanced breast cancer (MONALEESA-7): a randomised phase 3 trial.
In: Lancet Oncology, Bd. 19, Nr. 7: S. 904-915
Cristofanilli, Massimo; Turner, Nicholas C.; Bondarenko, Igor; Ro, Jungsil; Im, Seock-Ah; Masuda, Norikazu; Colleoni, Marco; DeMichele, Angela; Loi, Sherene; Verma, Sunil; Iwata, Hiroji; Harbeck, Nadia; Zhang, Ke; Theall, Kathy Puyana; Jiang, Yuqiu; Bartlett, Cynthia Huang; Koehler, Maria und Slamon, Dennis
(2016):
Fulvestrant plus palbociclib versus fulvestrant plus placebo for treatment of hormone-receptor-positive, HER2-negative metastatic breast cancer that progressed on previous endocrine therapy (PALOMA-3): final analysis of the multicentre, double-blind, phase 3 randomised controlled trial.
In: Lancet Oncology, Bd. 17, Nr. 4: S. 425-439
Diese Liste wurde am
Sat Nov 23 18:56:35 2024 CET
erstellt.